Monday, June 01, 2015 12:33:22 PM
That is just my point with Pfizer... not sure if they can think with the current people in charge of that company. And I repeat...
this is NOT the same Pfizer pharmaceutical that was the pharma giant in the 1990s. Totally different company now and it is beginning to show cracks.
As for the insurance companies required to pay the greatly increased cost? Insurance companies may have no choice but to abide by whatever comes down.
What is cheaper for insurance companies? Pay an additional cost for the ADF on the prescription opioid or pay out money for addicts hooked on prescription opioids?
The ADF is far cheaper.
Also with the increase in liability issues when more robust ADFs become available I really dont think insurance companies are going to have a choice. Either way insurance companies will make their money to cover additional costs. They always find ways to make money. The FDA puts a mandate of sorts through and there will be no choice. With companies like Purdue Pharma doing basically whatever they want the FDA may have no choice but to put a sort of mandate through. Ahhh the vicious circle.......LOL
this is NOT the same Pfizer pharmaceutical that was the pharma giant in the 1990s. Totally different company now and it is beginning to show cracks.
As for the insurance companies required to pay the greatly increased cost? Insurance companies may have no choice but to abide by whatever comes down.
What is cheaper for insurance companies? Pay an additional cost for the ADF on the prescription opioid or pay out money for addicts hooked on prescription opioids?
The ADF is far cheaper.
Also with the increase in liability issues when more robust ADFs become available I really dont think insurance companies are going to have a choice. Either way insurance companies will make their money to cover additional costs. They always find ways to make money. The FDA puts a mandate of sorts through and there will be no choice. With companies like Purdue Pharma doing basically whatever they want the FDA may have no choice but to put a sort of mandate through. Ahhh the vicious circle.......LOL
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
